» Articles » PMID: 27235792

Sam68 Modulates Apoptosis of Intestinal Epithelial Cells Via Mediating NF-κB Activation in Ulcerative Colitis

Overview
Journal Mol Immunol
Date 2016 May 29
PMID 27235792
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Sam68 (Src-associated substrate during mitosis of 68 KDa), also known as KHDRBS1 (KH domain containing, RNA binding, signal transduction associated 1), belongs to the prototypic member of the signal transduction activator of RNA (STAR) family of RNA-binding proteins. Sam68 is implicated in various cellular processes including RNA metabolism, apoptosis, signal transduction. Previous researches demonstrated that Sam68 regulated nuclear transcription factor kappa B (NF-κB) to induce inflammation. However, the expression and biological functions of Sam68 in ulcerative colitis (UC) are not clear. In this study, we reported for the first time that Sam68 was up-regulated in intestinal epithelial cells (IECs) of patients with UC. In DSS-induced mouse colitis model, we observed the overexpression of Sam68 accompanied with increased levels of IEC apoptotic markers (active caspase-3 and cleaved PARP) and NF-κB activation indicators (p-p65 and p-IκB) in colitis IECs. Co-localization of Sam68 with active caspase-3 (and p-p65) in IECs of the DSS-induced colitis group further indicated the possible involvement of NF-κB-mediated IEC apoptosis. Applying TNF-α-treated HT-29 cells as an in vitro IEC inflammation model, we confirmed the positive correlation amomg Sam68, NF-κB activation and caspase-dependent apoptosis. Immunofluorescence and immunoprecipitation assay identified nuclear translocation and physical interaction of Sam68 and NF-κB subunits in TNF-α-treated HT-29 cells. Besides, depletion of Sam68 by RNA interference greatly alleviated NF-κB activation and apoptosis in TNF-α-treated HT-29 cells. Taken together, our results indicated that Sam68 modulates apoptosis of intestinal epithelial cells via mediating NF-κB activation in UC.

Citing Articles

KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity.

Fan R, Liu F, Gong Q, Liu D, Tang S, Shen D Front Immunol. 2024; 15:1393801.

PMID: 38660302 PMC: 11041018. DOI: 10.3389/fimmu.2024.1393801.


SAM68 directs STING signaling to apoptosis in macrophages.

van der Horst D, Kurmasheva N, Marqvorsen M, Assil S, Rahimic A, Kollmann C Commun Biol. 2024; 7(1):283.

PMID: 38454028 PMC: 10920828. DOI: 10.1038/s42003-024-05969-1.


Role of Sam68 as an adaptor protein in inflammatory signaling.

Gowd V, Kass J, Sarkar N, Ramakrishnan P Cell Mol Life Sci. 2024; 81(1):89.

PMID: 38351330 PMC: 10864426. DOI: 10.1007/s00018-023-05108-9.


Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models.

Kong L, Chen S, Huang S, Zheng A, Gao S, Ye J Inflamm Res. 2024; 73(4):541-562.

PMID: 38345635 DOI: 10.1007/s00011-024-01854-z.


Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules.

Khajah M, Hawai S, Barakat A, Albaloushi A, Alkharji M, Masocha W Front Pharmacol. 2023; 14:1252174.

PMID: 38034999 PMC: 10687282. DOI: 10.3389/fphar.2023.1252174.